ASK REDCHAT ANYTHING ABOUT TAYSHA GENE THERAPIES, INC.
Taysha Gene Therapies, Inc. (NASDAQ: TSHA)
Listen to this Section
$5.55
-0.0050
(
-0.09% )
0.1K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| TSHA-102DetailsRett syndrome |
Phase 1/2 |
| TSHA-120DetailsGiant Axonal Neuropathy |
Failed |
| TSHA-118DetailsBatten Disease |
Failed |
| TSHA-101DetailsGM2 gangliosidosis |
Failed |
Market Data
|
| Open |
$5.55 |
| Previous Close |
$5.55 |
| Volume |
0.1K |
| Market Cap |
$1.59B |
| Day Range |
$5.40 - $5.61 |
| 52 Week Range |
$2.25 - $7.30 |
| Shares Outstanding |
287.36M |
| Change % |
-0.09% |
| Net Change |
▼ -0.0050 |
| Insider Ownership |
-0.16% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Year | 2020 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
15,692,621.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2025-06-03 |
Buy |
750000.00 |
Manning Paul B |
| 2024-07-01 |
Buy |
1333333.00 |
Manning Paul B |
| 2024-05-31 |
Sale |
-49220.00 |
Long Alison S |
| 2024-05-31 |
Sale |
-49220.00 |
Sepp-Lorenzino Laura |
| 2024-05-31 |
Sale |
-49220.00 |
Donenberg Phillip B. |
| 2024-05-31 |
Sale |
-49220.00 |
Stalfort John A III |
| 2024-02-06 |
Sale |
-1288.00 |
Alam Kamran |
| 2024-01-04 |
Sale |
-863617.00 |
Nagendran Sukumar |
| 2024-01-04 |
Sale |
-590413.00 |
Alam Kamran |
| 2024-01-04 |
Sale |
-1184688.00 |
Nolan Sean P. |